glp-1 eli lilly FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and hormone receptors - Eli Lilly's oral GLP-1 pill
Description
Globally, 90% of diabetes patients have TIIDM
We break down the link between the medication and this side effect, plus how to find relief.
Warning: Do not exceed the recommended daily dose
On the other hand, TIIDM is characterized by an imbalance between insulin levels and insulin sensitivity, resulting in persistent hyperglycemia
Tricia Rodriguez, Truveta senior applied research scientist & lead study author, explains the study findings concerning why GLP-1 users stop taking the drug.
